Your browser doesn't support javascript.
loading
Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma.
Gu, Chao; Upchurch, Katherine; Mamaril-Davis, James; Wiest, Matthew; Lanier, Bobby; Millard, Mark; Turner, Jacob; Joo, HyeMee; Oh, SangKon.
Afiliação
  • Gu C; Department of Immunology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Upchurch K; Institute for Biomedical Studies, Baylor University, Waco, Texas, USA.
  • Mamaril-Davis J; Department of Immunology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Wiest M; Department of Immunology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Lanier B; Institute for Biomedical Studies, Baylor University, Waco, Texas, USA.
  • Millard M; North Texas Institute for Clinical Trials, Ft Worth, Texas, USA.
  • Turner J; Martha Foster Lung Care Center, Baylor University Medical Center, Dallas, Texas, USA.
  • Joo H; Department of Mathematics and Statistics, Stephen F. Austin State University, Nacogdoches, Texas, USA.
  • Oh S; Department of Immunology, Mayo Clinic, Scottsdale, Arizona, USA.
Clin Exp Allergy ; 50(10): 1196-1199, 2020 10.
Article em En | MEDLINE | ID: mdl-32585057
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Antialérgicos / Omalizumab / Pulmão / Obesidade Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Antialérgicos / Omalizumab / Pulmão / Obesidade Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article